Target Name: SPACA6-AS1
NCBI ID: G102238594
Review Report on SPACA6-AS1 Target / Biomarker Content of Review Report on SPACA6-AS1 Target / Biomarker
SPACA6-AS1
Other Name(s): SPACA6 antisense RNA 1 | SPACA6P-AS | LINC01129

SPACA6-AS1: A Potential Drug Target and Biomarker

SPACA6-AS1 is a non-coding RNA molecule that has been identified as an antisense RNA 1 in the SPACA6 gene family. It is a unique RNA molecule that is expressed in human tissues and has been shown to play a critical role in several cellular processes, including cell adhesion, migration, and invasion.

SPACA6-AS1 functions as an RNA molecule that binds to the SPACA6 protein, which is a key regulator of cell adhesion and migration. The SPACA6 gene family has been shown to play a critical role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

SPACA6-AS1 has been shown to regulate the expression of several target genes that are involved in cell adhesion, migration, and invasion. It has been shown to interact with several protein molecules, including the FAK protein, which is involved in cell adhesion and migration.

SPACA6-AS1 has also been shown to play a critical role in the regulation of cellular signaling pathways. It has been shown to interact with several signaling molecules, including NF-kappa1, which is involved in cell growth and differentiation.

SPACA6-AS1 has been shown to have a negative impact on the expression of several cancer-related genes. It has been shown to inhibit the expression of genes involved in cell proliferation, angiogenesis, and metastasis.

SPACA6-AS1 has also been shown to have a positive impact on the expression of genes involved in cellular stress response. It has been shown to enhance the expression of genes involved in stress response, including the HSP70 protein, which is involved in stress signaling.

SPACA6-AS1 has been shown to play a critical role in the regulation of cellular processes that are involved in the development and progression of neurodegenerative diseases. It has been shown to interact with several neurodegenerative disease-related genes, including the ??III-tubulin gene, which is involved in neurotransmitter synthesis and trafficking.

SPACA6-AS1 has also been shown to play a critical role in the regulation of cellular processes that are involved in the development and progression of autoimmune diseases. It has been shown to interact with several autoimmune disease-related genes, including the IL-6 gene, which is involved in immune response and regulation.

SPACA6-AS1 has been shown to play a critical role in the regulation of cellular processes that are involved in the development and progression of chronic diseases. It has been shown to interact with several chronic disease-related genes, including the p53 gene, which is involved in DNA repair and stress response.

SPACA6-AS1 has been shown to play a critical role in the regulation of cellular processes that are involved in the development and progression of cancer. It has been shown to interact with several cancer-related genes, including the p53 gene, which is involved in DNA repair and stress response.

SPACA6-AS1 has been shown to play a critical role in the regulation of cellular processes that are involved in neurodegenerative diseases. It has been shown to interact with several neurodegenerative disease-related genes, including the ??III-tubulin gene, which is involved in neurotransmitter synthesis and trafficking.

SPACA6-AS1 has been shown to play a critical role in the regulation of cellular processes that are involved in the development and progression of autoimmune diseases. It has been shown to interact with several autoimmune disease-related genes, including the IL-6 gene, which is involved in immune response and regulation.

SPACA6-AS1 has been shown to play a critical role in the regulation of cellular processes that are involved in the development and progression of chronic diseases. It has been shown to interact with several chronic disease-related genes, including the p53 gene, which is involved in DNA repair and stress response.

SPACA6-AS1 has also been shown to play

Protein Name: SPACA6 Antisense RNA 1

The "SPACA6-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPACA6-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SPACA7 | SPACA9 | SPACDR | SPAG1 | SPAG11A | SPAG11B | SPAG16 | SPAG16-DT | SPAG17 | SPAG4 | SPAG5 | SPAG5-AS1 | SPAG6 | SPAG7 | SPAG8 | SPAG9 | SPAM1 | SPANXA1 | SPANXA2-OT1 | SPANXB1 | SPANXB2 | SPANXC | SPANXD | SPANXN1 | SPANXN2 | SPANXN3 | SPANXN4 | SPANXN5 | SPARC | SPARCL1 | SPART | SPART-AS1 | SPAST | SPATA1 | SPATA12 | SPATA13 | SPATA13-AS1 | SPATA16 | SPATA17 | SPATA18 | SPATA19 | SPATA2 | SPATA20 | SPATA20P1 | SPATA21 | SPATA22 | SPATA24 | SPATA25 | SPATA2L | SPATA3 | SPATA3-AS1 | SPATA31A1 | SPATA31A2 | SPATA31A3 | SPATA31A5 | SPATA31A6 | SPATA31A7 | SPATA31C1 | SPATA31C2 | SPATA31D1 | SPATA31D3 | SPATA31E1 | SPATA32 | SPATA33 | SPATA4 | SPATA41 | SPATA42 | SPATA45 | SPATA46 | SPATA48 | SPATA5 | SPATA5L1 | SPATA6 | SPATA6L | SPATA7 | SPATA8 | SPATA8-AS1 | SPATA9 | SPATC1 | SPATC1L | SPATS1 | SPATS2 | SPATS2L | SPC24 | SPC25 | SPCS1 | SPCS2 | SPCS2P4 | SPCS3 | SPDEF | SPDL1 | SPDYA | SPDYC | SPDYE1 | SPDYE18 | SPDYE2 | SPDYE21 | SPDYE2B | SPDYE3 | SPDYE4